Tell me more about this care gap: Formal oncology treatment recommendations and rationale documentation

Care Gap Analysis: Formal Oncology Treatment Recommendations & Rationale Documentation

Based on my review of Marlo's [ID removed] I can see a significant care gap that's important to address.

What I'm Observing in the Documents

The Challenge: Your records show extensive diagnostic work (pathology, molecular testing, imaging) and a detailed research strategy document outlining potential treatment options. However, there's a notable gap between these two: formal, documented oncology treatment recommendations with clear clinical reasoning from your care team.

Here's what I mean:

What's Well-Documented:

✅ Pathology findings - Low-grade spindle cell neoplasm of myofibroblastic origin (from CHLA and Mayo Clinic) ✅ Molecular testing - Exome sequencing, whole genome sequencing, immunostaining profiles ✅ Research strategy - A comprehensive working document exploring 6 major decision areas (radiation, biopsy/profiling, systemic therapy, vaccine, FAP-targeted therapy, CAR-T trials) ✅ Expert consultations - Input from multiple pathologists and specialists

What's Missing or Unclear:

❌ Formal treatment plan - A documented oncology recommendation that says: "Based on Marlo's diagnosis and molecular findings, we recommend X treatment because Y" ❌ Clinical rationale - Written explanation of why specific treatments are being considered or prioritized ❌ Treatment sequencing - Clear documentation of the order and timing of interventions ❌ Risk/benefit discussion - Documented conversation about what each option offers and what the tradeoffs are

Why This Matters

According to the NCCN Guidelines for Soft Tissue Sarcoma, treatment decisions should be based on:

• Tumor grade and stage
• Molecular/genetic characteristics
• Patient age and performance status
• Clear documentation of the multidisciplinary team's recommendations

Your situation is complex because Marlo's tumor is rare and diagnostically challenging (as noted in the pathology addendum: "diagnosis remains elusive"). This actually makes formal documentation more important, not less.

The Care Gap in Context

The "Marlo's Treatment & Research Strategy" document is excellent for exploring options, but it reads as a working/planning document rather than a formal treatment recommendation. It has:

• Questions to answer
• Options to investigate
• Action items and timelines
• Spaces for "team input/comments"

What it doesn't have:

• A primary recommendation from the oncology team
• Clinical reasoning for why certain approaches are prioritized
• Documented consensus from the multidisciplinary team about the treatment plan

Specific Questions to Ask Your Oncology Team

To close this gap, I'd recommend asking:

1. "Can you provide a formal written treatment recommendation that explains which approach you recommend first and why?" (This should include the clinical reasoning based on Marlo's specific diagnosis and molecular findings)

2. "What is the multidisciplinary team's consensus on treatment sequencing?" (Which interventions should happen first, and what's the rationale for that order?)

3. "For each treatment option being considered, can you document the potential benefits and risks specific to Marlo's case?" (This helps with informed decision-making)

4. "How will you monitor response to treatment, and what would trigger a change in strategy?" (This clarifies the plan if something isn't working)

5. "Given that the diagnosis was challenging, how confident is the team in the current diagnosis, and does that affect treatment recommendations?" (This acknowledges the diagnostic uncertainty and how it impacts planning)

How to Move Forward

Request from your care team:

• A formal treatment plan document (separate from the research strategy document) that includes:
  • Recommended primary treatment
  • Clinical reasoning
  • Alternative options considered and why they weren't chosen
  • Timeline for implementation
  • Monitoring/response assessment plan

This is standard practice and helps ensure:

• Clear communication between all team members
• Informed consent (you understand the reasoning)
• A documented baseline to compare against if treatment needs adjustment
• Better coordination if you seek second opinions

---

Important Context

The research strategy document shows your team is thinking comprehensively about Marlo's care—that's excellent. But research options and formal treatment recommendations serve different purposes. You need both:

• Formal treatment plan = What we're doing now and why
• Research strategy = What additional options we're exploring and investigating

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.